(The FDA just approved doses of Foundayo up to 17.2 milligrams, although Novo Nordisk says this is equivalent to the 36-milligram capsules used in phase 3 clinical trials.) In it, Novo Nordisk noted that people on the Wegovy pill had significantly greater weight loss than those on Foundayo
This delay supports eating smaller portions and reducing calories, driving sustained weight reduction
Novo Nordisk (NVO) Novo Nordisk has long held the crown in the GLP-1 market, leveraging its first-mover advantage with Ozempic and Wegovy
Hypoglycaemia risk is the primary safety consideration, along with potential joint swelling and carpal tunnel effects at higher doses
Strengthens the Immune System Helps the body repair and defend itself better
A new branded semaglutide drug named Poviztra was introduced in India by Emcure Pharmaceuticals in 2025 for USD 103 a month, well under the prices offered by competing drugs, ranging between USD 165 and 324